Alice Sitch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alice Sitch has a total of 990 co-authors. Here are the top co-authors by number of shared publications:
- Peymane Adab
Institute of Applied Health Research, University of Birmingham, Birmingham, UK
20 shared publications - Jonathan James Deeks
Department of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK
16 shared publications - Andrew Graeme Schache
Liverpool Head & Neck Centre Liverpool University Hospitals NHS Foundation Trust, Aintree University Hospital Liverpool UK
15 shared publications - Andrew Hartley
Hall-Edwards Radiotherapy Research Group, Queen Elizabeth Hospital, Birmingham, UK
15 shared publications - Anna Long
15Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
15 shared publications - Brendan Conn
Department of Pathology, NHS Lothian, Royal Infirmary of Edinburgh, Little France Crescent, Edinburgh, EH16 4SA, UK
15 shared publications
Latest Publications
- Open Access
- 4 June 2026
- Published by Oxford University Press (OUP) in The Journal of Applied Laboratory Medicine
- Vol. 11 (5) , 1184-1196
Sample Size Guidance and Justification for Studies of Biological Variability
Background: Good estimates of analytical, within-subject, and between-subject variation, from appropriately designed biological variability studies, allow the potential for a biomarker to diagnose and monitor disease to be assessed in addition to setting goals for test performance. Sample sizes for these studies require consideration of the numbers of participants (n1), observations per participant (n2), and replicates of each observation (n3). Little guidance exists to compute these values. Methods: Data was simulated to examine the effect of changes in each component of sample size on analytical, within-subject, and between-subject variability, and on common measures of variability including the coefficient of variation (CV), reference change values (RCV), and index of individuality (II). Results: Simulations showed the precision of estimated results (CVs, RCVs, and IIs) for varying sample sizes. Greater numbers of participants increased the precision of estimated analytical, within-subject, and between-subject variability; increasing the number of observations per participant increases the precision of estimates of analytical and within-subject variability; and increasing the number of replicates of observations per participants increases precision of only analytical variability. Conclusions: The sample sizes for biological variability studies can be planned better, with consideration of the primary estimate evaluated in a study and resource used to increase the precision of this estimate. Studies with sample sizes too small to achieve reasonable precision can be redeveloped or abandoned, minimizing research waste. If the desired precision of variability components is known, values for the sample size (number of participants, observations and replicates of observations) can be determined.
- 4 June 2026
- Published by Oxford University Press (OUP) in The Journal of Applied Laboratory Medicine
- Vol. 11 (5) , 1184-1196
Open AccessSample Size Guidance and Justification for Studies of Biological Variability
Background: Good estimates of analytical, within-subject, and between-subject variation, from appropriately designed biological variability studies, allow the potential for a biomarker to diagnose and monitor disease to be assessed in addition to setting goals for test performance. Sample sizes for these studies require consideration of the numbers of participants (n1), observations per participant (n2), and replicates of each observation (n3). Little guidance exists to compute these values. Methods: Data was simulated to examine the effect of changes in each component of sample size on analytical, within-subject, and between-subject variability, and on common measures of variability including the coefficient of variation (CV), reference change values (RCV), and index of individuality (II). Results: Simulations showed the precision of estimated results (CVs, RCVs, and IIs) for varying sample sizes. Greater numbers of participants increased the precision of estimated analytical, within-subject, and between-subject variability; increasing the number of observations per participant increases the precision of estimates of analytical and within-subject variability; and increasing the number of replicates of observations per participants increases precision of only analytical variability. Conclusions: The sample sizes for biological variability studies can be planned better, with consideration of the primary estimate evaluated in a study and resource used to increase the precision of this estimate. Studies with sample sizes too small to achieve reasonable precision can be redeveloped or abandoned, minimizing research waste. If the desired precision of variability components is known, values for the sample size (number of participants, observations and replicates of observations) can be determined.
- Open Access
- 17 May 2026
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 13 (1) , e003853
Within-individual variation of spirometry measurements in primary care: a retrospective cohort study
Background: Forced expiratory volume in 1 s (FEV 1 ) and forced vital capacity (FVC) are two of the most common measurements in spirometry, which are used for the diagnosis and monitoring of respiratory disease. Within-individual variation in measured FEV 1 and FVC may affect their clinical utility but estimates of this are based on limited and often poor-quality data. Methods: A retrospective cohort study was performed. Data on FEV 1 and FVC results and sociodemographic, lifestyle and comorbidity covariates were extracted from the IQVIA Medical Research Database. A minimum of four measurements in the same individual within a 6-month time period from the first measurement was the only inclusion criterion. Within-individual measured variation was calculated as a coefficient of variation (CV) using a linear regression random effects model using within-subject variance to estimate CV for the whole population and various subgroups. Results: 4412 participants for FEV 1 and 3567 participants for FVC were included in the main study. The mean number of measurements per individual in the 6-month period was 4.8 (SD 2.3) for FEV 1 and 5.1 (SD 3.5) for FVC. The overall CV for FEV 1 was 22.4% (95% CI 22.1% to 22.8%) and for FVC was 15.2% (95% CI 15.0% to 15.5%). This is much higher than seen in a previous systematic review of spirometry variation. CV increased as mean patient FEV 1 and FVC decreased. Conclusions: Estimated within-individual variation in this analysis of real-world data is much higher than previously reported. Variation increases with more severe disease status. This has important implications for diagnosis, monitoring and clinical decision-making.
- 17 May 2026
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 13 (1) , e003853
Open AccessWithin-individual variation of spirometry measurements in primary care: a retrospective cohort study
Background: Forced expiratory volume in 1 s (FEV 1 ) and forced vital capacity (FVC) are two of the most common measurements in spirometry, which are used for the diagnosis and monitoring of respiratory disease. Within-individual variation in measured FEV 1 and FVC may affect their clinical utility but estimates of this are based on limited and often poor-quality data. Methods: A retrospective cohort study was performed. Data on FEV 1 and FVC results and sociodemographic, lifestyle and comorbidity covariates were extracted from the IQVIA Medical Research Database. A minimum of four measurements in the same individual within a 6-month time period from the first measurement was the only inclusion criterion. Within-individual measured variation was calculated as a coefficient of variation (CV) using a linear regression random effects model using within-subject variance to estimate CV for the whole population and various subgroups. Results: 4412 participants for FEV 1 and 3567 participants for FVC were included in the main study. The mean number of measurements per individual in the 6-month period was 4.8 (SD 2.3) for FEV 1 and 5.1 (SD 3.5) for FVC. The overall CV for FEV 1 was 22.4% (95% CI 22.1% to 22.8%) and for FVC was 15.2% (95% CI 15.0% to 15.5%). This is much higher than seen in a previous systematic review of spirometry variation. CV increased as mean patient FEV 1 and FVC decreased. Conclusions: Estimated within-individual variation in this analysis of real-world data is much higher than previously reported. Variation increases with more severe disease status. This has important implications for diagnosis, monitoring and clinical decision-making.
- Open Access
Prognostic score for predicting respiratory admissions among patients with chronic obstructive pulmonary disease in primary care: development and validation in population cohorts (Birmingham Lung Improvement Studies (BLISS))
Objective To predict the two year risk of respiratory admission to hospital among individuals with chronic obstructive pulmonary disease (COPD), with the development and validation (internal and external) of a prognostic score. Design Model development and validation in population cohorts. Setting Birmingham Lung Improvement Studies (BLISS) cohort of new and existing patients with COPD in primary care (model development and internal validation); Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) international cohort and UK primary care Clinical Practice Research Datalink (CPRD) Aurum database linked with Hospital Episode Statistics (external validation). Participants 1894 patients with new and existing COPD from BLISS cohort; 1749 patients with moderate to very severe COPD from ECLIPSE cohort; 27 340 patients with COPD from CPRD Aurum database linked with Hospital Episode Statistics. Main outcome measures One or more respiratory admissions within two years of cohort entry for development, internal validation, and external validation in CPRD; severe exacerbation within two years for external validation in ECLIPSE cohort. The model was developed from 23 candidate predictors by using multivariable logistic regression with bootstrapping for internal validation and adjustment for overfitting and optimism. Discrimination and calibration were assessed at each stage. Net benefit of the score (clinical utility) was examined across a range clinically relevant risk thresholds compared with use of individual score components. Subgroup and sensitivity analyses were conducted in the CPRD. The BLISS score was directly compared with the Bertens’ score in the ECLIPSE cohort. Clinical implementation was explored with relevant stakeholders. Results Six predictors were retained (age, COPD Assessment Test score, respiratory admissions in the previous 12 months, body mass index, diabetes, forced expiratory volume in 1 second % predicted) to form the BLISS score for estimating an individual’s two year risk of respiratory admission. The score had similar discrimination performance on internal validation (optimism adjusted C statistic 0.73 (95% confidence interval 0.70 to 0.77)) and external validation (ECLIPSE: C=0.73 (0.71 to 0.76); CPRD: C=0.71 (0.70 to 0.72)) and good calibration performance in the BLISS (slope=0.87 (95% confidence interval 0.73 to 1.02), CPRD (0.89 (0.85 to 0.93)), and ECLIPSE (0.92 (0.79 to 1.05) cohorts). Stratified analysis in the CPRD cohort showed that it was robust in different population subgroups. Net benefit analyses showed superiority of the BLISS score over individual predictors and the Bertens’ score (C=0.68 (0.65 to 0.71); calibration slope 0.68 (0.56 to 0.81)). Conclusions The BLISS score showed good performance in estimating individual risk of respiratory admission (within two years) in cohorts containing patients from different settings and geographical locations and with different severities of COPD. Four of the included six variables are readily available in primary care records, and two are partially available but easy to collect. Impact evaluations are now needed to fully study use of the score in clinical care. Study registration ECLIPSE ClinicalTrials.gov NCT00292552.
Open AccessPrognostic score for predicting respiratory admissions among patients with chronic obstructive pulmonary disease in primary care: development and validation in population cohorts (Birmingham Lung Improvement Studies (BLISS))
Objective To predict the two year risk of respiratory admission to hospital among individuals with chronic obstructive pulmonary disease (COPD), with the development and validation (internal and external) of a prognostic score. Design Model development and validation in population cohorts. Setting Birmingham Lung Improvement Studies (BLISS) cohort of new and existing patients with COPD in primary care (model development and internal validation); Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) international cohort and UK primary care Clinical Practice Research Datalink (CPRD) Aurum database linked with Hospital Episode Statistics (external validation). Participants 1894 patients with new and existing COPD from BLISS cohort; 1749 patients with moderate to very severe COPD from ECLIPSE cohort; 27 340 patients with COPD from CPRD Aurum database linked with Hospital Episode Statistics. Main outcome measures One or more respiratory admissions within two years of cohort entry for development, internal validation, and external validation in CPRD; severe exacerbation within two years for external validation in ECLIPSE cohort. The model was developed from 23 candidate predictors by using multivariable logistic regression with bootstrapping for internal validation and adjustment for overfitting and optimism. Discrimination and calibration were assessed at each stage. Net benefit of the score (clinical utility) was examined across a range clinically relevant risk thresholds compared with use of individual score components. Subgroup and sensitivity analyses were conducted in the CPRD. The BLISS score was directly compared with the Bertens’ score in the ECLIPSE cohort. Clinical implementation was explored with relevant stakeholders. Results Six predictors were retained (age, COPD Assessment Test score, respiratory admissions in the previous 12 months, body mass index, diabetes, forced expiratory volume in 1 second % predicted) to form the BLISS score for estimating an individual’s two year risk of respiratory admission. The score had similar discrimination performance on internal validation (optimism adjusted C statistic 0.73 (95% confidence interval 0.70 to 0.77)) and external validation (ECLIPSE: C=0.73 (0.71 to 0.76); CPRD: C=0.71 (0.70 to 0.72)) and good calibration performance in the BLISS (slope=0.87 (95% confidence interval 0.73 to 1.02), CPRD (0.89 (0.85 to 0.93)), and ECLIPSE (0.92 (0.79 to 1.05) cohorts). Stratified analysis in the CPRD cohort showed that it was robust in different population subgroups. Net benefit analyses showed superiority of the BLISS score over individual predictors and the Bertens’ score (C=0.68 (0.65 to 0.71); calibration slope 0.68 (0.56 to 0.81)). Conclusions The BLISS score showed good performance in estimating individual risk of respiratory admission (within two years) in cohorts containing patients from different settings and geographical locations and with different severities of COPD. Four of the included six variables are readily available in primary care records, and two are partially available but easy to collect. Impact evaluations are now needed to fully study use of the score in clinical care. Study registration ECLIPSE ClinicalTrials.gov NCT00292552.
- Open Access
- 12 November 2025
- Published by Springer Nature in International Journal of Behavioral Nutrition and Physical Activity
- Vol. 22 (1) , 1-18
Economic evaluation of the national school food standards across secondary schools in the Midlands, UK (the FUEL study): methodological challenges of undertaking health economics research within non-health settings
Background: Economic evaluations of complex public health interventions are becoming increasingly important. This presents health economists with challenges of adapting methodologies originally designed for healthcare to other contexts, such as education. This study presents an economic evaluation of the UK School Food Standards (SFS), with a particular focus on the methodological challenges involved. Methods: The economic evaluation was conducted alongside an observational study comparing the SFS-mandated secondary schools to non-mandated schools in the Midlands (UK). Costs of food provision and SFS implementation were collected directly from schools and supplemented by secondary data on schools’ catering expenditure. The outcomes included dietary intake, dental health, health-related quality of life (HRQoL), and educational performance, collected from pupils and secondary data. The analysis comprised a micro-costing, cost-consequence, and an exploratory cost-utility analysis, from school and societal perspectives. Results: Data were collected from 36 schools and 2,543 pupils. We found mandated schools spent less on food provision compared to non-mandated schools, and pupils attending mandated schools had marginally better HRQoL, dental health, and slightly worse nutritional intake. Mandated schools performed worse according to the educational outcomes. There were large amounts of missing cost data despite repeated data collection attempts, and the results of the cost-utility analysis were uncertain. Discussion: We found no clear evidence on the cost-effectiveness of the SFS in secondary schools, likely due to substantial variation in implementation and compliance across both mandated and non-mandated schools, as well as multiple challenges, including the COVID-19 pandemic, difficulties in collecting cost data from schools, and the complexity of the study context. This study highlights the challenges of primary cost data collection for evaluating complex interventions and the need to balance data accuracy with the resources required. As economic evaluations of school-based interventions become more common, there is a growing need to refine methods for such evaluations.
- 12 November 2025
- Published by Springer Nature in International Journal of Behavioral Nutrition and Physical Activity
- Vol. 22 (1) , 1-18
Open AccessEconomic evaluation of the national school food standards across secondary schools in the Midlands, UK (the FUEL study): methodological challenges of undertaking health economics research within non-health settings
Background: Economic evaluations of complex public health interventions are becoming increasingly important. This presents health economists with challenges of adapting methodologies originally designed for healthcare to other contexts, such as education. This study presents an economic evaluation of the UK School Food Standards (SFS), with a particular focus on the methodological challenges involved. Methods: The economic evaluation was conducted alongside an observational study comparing the SFS-mandated secondary schools to non-mandated schools in the Midlands (UK). Costs of food provision and SFS implementation were collected directly from schools and supplemented by secondary data on schools’ catering expenditure. The outcomes included dietary intake, dental health, health-related quality of life (HRQoL), and educational performance, collected from pupils and secondary data. The analysis comprised a micro-costing, cost-consequence, and an exploratory cost-utility analysis, from school and societal perspectives. Results: Data were collected from 36 schools and 2,543 pupils. We found mandated schools spent less on food provision compared to non-mandated schools, and pupils attending mandated schools had marginally better HRQoL, dental health, and slightly worse nutritional intake. Mandated schools performed worse according to the educational outcomes. There were large amounts of missing cost data despite repeated data collection attempts, and the results of the cost-utility analysis were uncertain. Discussion: We found no clear evidence on the cost-effectiveness of the SFS in secondary schools, likely due to substantial variation in implementation and compliance across both mandated and non-mandated schools, as well as multiple challenges, including the COVID-19 pandemic, difficulties in collecting cost data from schools, and the complexity of the study context. This study highlights the challenges of primary cost data collection for evaluating complex interventions and the need to balance data accuracy with the resources required. As economic evaluations of school-based interventions become more common, there is a growing need to refine methods for such evaluations.
- Open Access
- 7 March 2025
- Published by Wiley in International Journal of Mental Health Nursing
- Vol. 34 (2) , e70018
Postnatal Depression Beyond 12 Months: A Systematic Review and Meta‐Analysis
Traditionally, postnatal depression (PND) has been considered as depression in the first year after giving birth, although it has been argued that the 12‐month cut‐off may be somewhat arbitrary. Specialist perinatal mental health services in England have recently been extended to include women in their second year postpartum; however, there is no good estimate for the prevalence of PND beyond the first year. This review aimed to obtain the best estimate of the prevalence of PND in the second postpartum year. Eligible studies were those that assessed PND and provided a point prevalence using a validated screening tool or clinical diagnosis at least once beyond the first 12 months in women over the age of 18 years in any country. Studies were excluded if they only included women who were already depressed or had elevated depression scores at baseline. PubMed, Embase, Web of Science, CINAHL and PsychINFO were searched in January 2021 (and updated in February 2024) for studies that included the prevalence of PND beyond the first 12 postnatal months. Study quality was assessed using Cochrane's ROBINS‐I and Risk of Bias 2 tools. Prevalence data were combined in meta‐analysis using prediction intervals (PIs). A total of 6340 papers were found, and of these, 32 studies including 57210 participants across 18 countries met the inclusion criteria and were meta‐analysed. The prevalence of PND in the second year (13–24 months) was 15% (95% confidence interval [CI] 12%, 17%; 95% PI 4%, 30%) and similar to that in the first year, 16% (95% CI 14%, 19%; 95% PI 6%, 31%). Despite considerable heterogeneity, common in meta‐analysis of prevalence studies, findings show that a similar proportion of women experience PND in the second year after birth.
- 7 March 2025
- Published by Wiley in International Journal of Mental Health Nursing
- Vol. 34 (2) , e70018
Open AccessPostnatal Depression Beyond 12 Months: A Systematic Review and Meta‐Analysis
Traditionally, postnatal depression (PND) has been considered as depression in the first year after giving birth, although it has been argued that the 12‐month cut‐off may be somewhat arbitrary. Specialist perinatal mental health services in England have recently been extended to include women in their second year postpartum; however, there is no good estimate for the prevalence of PND beyond the first year. This review aimed to obtain the best estimate of the prevalence of PND in the second postpartum year. Eligible studies were those that assessed PND and provided a point prevalence using a validated screening tool or clinical diagnosis at least once beyond the first 12 months in women over the age of 18 years in any country. Studies were excluded if they only included women who were already depressed or had elevated depression scores at baseline. PubMed, Embase, Web of Science, CINAHL and PsychINFO were searched in January 2021 (and updated in February 2024) for studies that included the prevalence of PND beyond the first 12 postnatal months. Study quality was assessed using Cochrane's ROBINS‐I and Risk of Bias 2 tools. Prevalence data were combined in meta‐analysis using prediction intervals (PIs). A total of 6340 papers were found, and of these, 32 studies including 57210 participants across 18 countries met the inclusion criteria and were meta‐analysed. The prevalence of PND in the second year (13–24 months) was 15% (95% confidence interval [CI] 12%, 17%; 95% PI 4%, 30%) and similar to that in the first year, 16% (95% CI 14%, 19%; 95% PI 6%, 31%). Despite considerable heterogeneity, common in meta‐analysis of prevalence studies, findings show that a similar proportion of women experience PND in the second year after birth.
- Open Access
- 20 December 2024
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 24 (1) , 1-9
Optimising research investment by simulating and evaluating monitoring strategies to inform a trial: a simulation of liver fibrosis monitoring
The aim of the study was to investigate the development of evidence-based monitoring strategies in a population with progressive or recurrent disease. A simulation study of monitoring strategies using a new biomarker (ELF) for the detection of liver cirrhosis in people with known liver fibrosis was undertaken alongside a randomised controlled trial (ELUCIDATE). Existing data and expert opinion were used to estimate the progression of disease and the performance of repeat testing with ELF. Knowledge of the true disease status in addition to the observed test results for a cohort of simulated patients allowed various monitoring strategies to be implemented, evaluated and validated against trial data. Several monitoring strategies ranging in complexity were successfully modelled and compared regarding the timing of detection of disease, the duration of monitoring, and the predictive value of a positive test result. The results of sensitivity analysis showed the importance of accurate data to inform the simulation. Results of the simulation were similar to those from the trial. Monitoring data can be simulated and strategies compared given adequate knowledge of disease progression and test performance. Such exercises should be carried out to ensure optimal strategies are evaluated in trials thus reducing research waste. Monitoring data can be generated and monitoring strategies can be assessed if data is available on the monitoring test performance and the test variability. This work highlights the data necessary and the general method for evaluating the performance of monitoring strategies, allowing appropriate strategies to be selected for evaluation. Modelling work should be conducted prior to full scale investigation of monitoring strategies, allowing optimal monitoring strategies to be assessed.
- 20 December 2024
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 24 (1) , 1-9
Open AccessOptimising research investment by simulating and evaluating monitoring strategies to inform a trial: a simulation of liver fibrosis monitoring
The aim of the study was to investigate the development of evidence-based monitoring strategies in a population with progressive or recurrent disease. A simulation study of monitoring strategies using a new biomarker (ELF) for the detection of liver cirrhosis in people with known liver fibrosis was undertaken alongside a randomised controlled trial (ELUCIDATE). Existing data and expert opinion were used to estimate the progression of disease and the performance of repeat testing with ELF. Knowledge of the true disease status in addition to the observed test results for a cohort of simulated patients allowed various monitoring strategies to be implemented, evaluated and validated against trial data. Several monitoring strategies ranging in complexity were successfully modelled and compared regarding the timing of detection of disease, the duration of monitoring, and the predictive value of a positive test result. The results of sensitivity analysis showed the importance of accurate data to inform the simulation. Results of the simulation were similar to those from the trial. Monitoring data can be simulated and strategies compared given adequate knowledge of disease progression and test performance. Such exercises should be carried out to ensure optimal strategies are evaluated in trials thus reducing research waste. Monitoring data can be generated and monitoring strategies can be assessed if data is available on the monitoring test performance and the test variability. This work highlights the data necessary and the general method for evaluating the performance of monitoring strategies, allowing appropriate strategies to be selected for evaluation. Modelling work should be conducted prior to full scale investigation of monitoring strategies, allowing optimal monitoring strategies to be assessed.
- Open Access
- 1 December 2024
- Published by National Institute for Health and Care Research in Global Health Research
- p. 1-17
COPD burden and healthcare management across four middle-income countries within the Breathe Well research programme: a descriptive study
Background: Chronic obstructive pulmonary disease is one of the world’s leading causes of morbidity and mortality, with many low- and middle-income countries still experiencing an increase. Effective management requires a strong primary healthcare system, to prevent, diagnose in a timely way, and manage prevalent disease for a long period of time through to end of life, but this is inadequate in many middle-income countries. The Breathe Well programme was a multinational collaboration between the University of Birmingham, United Kingdom, and partner institutions in four middle-income countries: Brazil, China, Georgia and North Macedonia. This review, conducted at the start of the programme, aimed to set the context for our research programme and future research, health care and policy needs by describing these four national health systems, risk factors, current burden and management of chronic obstructive pulmonary disease patients. Design and methods: A descriptive review based on publicly available data identified from MEDLINE, national and international websites, supplemented by local expert opinion. For each of the included middle-income countries, we present and discuss the ability of the healthcare systems to effectively diagnose and manage chronic obstructive pulmonary disease, the barriers and limitations, including history of the healthcare system, organisation and governance, financing and medicines. The health and health care of chronic obstructive pulmonary disease patients are further illustrated by a hypothetical patient case developed with local clinical experts. Results: While the sizes and features of the populations differ, the number of doctors tends to be low across most countries, the number of smokers high, the out-of-pocket expenses also high and the provision of diagnosis and management for chronic obstructive pulmonary disease in primary care suboptimal. Primary prevention including smoking cessation is insufficient across the participating countries. Cost and availability of care and medications are common barriers to effective chronic obstructive pulmonary disease management. Limitations: This study is not a comprehensive systematic review. It provides a useful broad description of the subject, but we did not seek to produce detailed accounts. Discussion: While there is vast diversity in settings and context, some challenges appeared to be shared: a lack of human and material resources in the primary care systems with an apparent power imbalance between primary and secondary care, pushing care burden to secondary care and potentially worsening geographic and economic health inequities. High cost (relative to average earnings) and low accessibility of long-term medications lead to high out-of-pocket expenditure, affecting quality and equity. There is generally suboptimal primary prevention with high smoking rates and high levels of air pollution. Improvement of prevention, diagnosis and management of chronic obstructive pulmonary disease via stronger primary care could help reduce health inequalities. Future work: This study provided useful context for prioritising research questions within the Breathe Well programme and beyond. Research recommendations included assessment of resource-effective methods for primary prevention, screening and community-led management of chronic obstructive pulmonary disease cases, as well as mapping the educational needs of primary care staff which were then prioritised by local stakeholders including patients, clinicians, healthcare managers and policy-makers. It will be essential to update information on local context at regular intervals to ensure currency of research plans. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Global Health Research programme as award number 16/137/95.
- 1 December 2024
- Published by National Institute for Health and Care Research in Global Health Research
- p. 1-17
Open AccessCOPD burden and healthcare management across four middle-income countries within the Breathe Well research programme: a descriptive study
Background: Chronic obstructive pulmonary disease is one of the world’s leading causes of morbidity and mortality, with many low- and middle-income countries still experiencing an increase. Effective management requires a strong primary healthcare system, to prevent, diagnose in a timely way, and manage prevalent disease for a long period of time through to end of life, but this is inadequate in many middle-income countries. The Breathe Well programme was a multinational collaboration between the University of Birmingham, United Kingdom, and partner institutions in four middle-income countries: Brazil, China, Georgia and North Macedonia. This review, conducted at the start of the programme, aimed to set the context for our research programme and future research, health care and policy needs by describing these four national health systems, risk factors, current burden and management of chronic obstructive pulmonary disease patients. Design and methods: A descriptive review based on publicly available data identified from MEDLINE, national and international websites, supplemented by local expert opinion. For each of the included middle-income countries, we present and discuss the ability of the healthcare systems to effectively diagnose and manage chronic obstructive pulmonary disease, the barriers and limitations, including history of the healthcare system, organisation and governance, financing and medicines. The health and health care of chronic obstructive pulmonary disease patients are further illustrated by a hypothetical patient case developed with local clinical experts. Results: While the sizes and features of the populations differ, the number of doctors tends to be low across most countries, the number of smokers high, the out-of-pocket expenses also high and the provision of diagnosis and management for chronic obstructive pulmonary disease in primary care suboptimal. Primary prevention including smoking cessation is insufficient across the participating countries. Cost and availability of care and medications are common barriers to effective chronic obstructive pulmonary disease management. Limitations: This study is not a comprehensive systematic review. It provides a useful broad description of the subject, but we did not seek to produce detailed accounts. Discussion: While there is vast diversity in settings and context, some challenges appeared to be shared: a lack of human and material resources in the primary care systems with an apparent power imbalance between primary and secondary care, pushing care burden to secondary care and potentially worsening geographic and economic health inequities. High cost (relative to average earnings) and low accessibility of long-term medications lead to high out-of-pocket expenditure, affecting quality and equity. There is generally suboptimal primary prevention with high smoking rates and high levels of air pollution. Improvement of prevention, diagnosis and management of chronic obstructive pulmonary disease via stronger primary care could help reduce health inequalities. Future work: This study provided useful context for prioritising research questions within the Breathe Well programme and beyond. Research recommendations included assessment of resource-effective methods for primary prevention, screening and community-led management of chronic obstructive pulmonary disease cases, as well as mapping the educational needs of primary care staff which were then prioritised by local stakeholders including patients, clinicians, healthcare managers and policy-makers. It will be essential to update information on local context at regular intervals to ensure currency of research plans. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Global Health Research programme as award number 16/137/95.
- Open Access
- 1 November 2024
- Published by National Institute for Health and Care Research in Public Health Research
- Vol. 12 (12) , 1-167
School food policy in secondary schools in England and its impact on adolescents’ diets and dental health: the FUEL multiple-methods study
Background: School food standards are a legal requirement for state-funded schools in England and are designed to promote healthy eating in pupils. However, state-funded academies/free schools established between 2010 and 2014 are exempt from this legislation. To complement the school food standards, the government launched the School Food Plan in 2013, which outlines voluntary actions that schools can take to support healthy eating and increase school meal uptake. There has been little evaluation of the school food standards and School Food Plan in secondary schools. Objectives: To compare implementation and costs of the school food standards and School Food Plan, and pupil dietary and dental outcomes in two groups of secondary schools: those mandated and those not mandated to comply with the school food standards legislation. Methods: An observational, multiple-methods study. We sampled state-funded secondary school academies/free schools, pupils aged 11–15 years, and school staff/governors with a role in food provision/education from the Midlands. We collected qualitative data in four schools. The primary outcome was pupil free sugar intake at lunch; across the school day; and during 24-hours. Secondary outcomes were additional nutritional outcomes and dental caries measures. We assessed school food standards/School Food Plan implementation and costs using researcher observation, document analysis, and surveys with staff/governors, schools and pupils. Dietary intake and dental outcomes were measured online using 24-hour dietary recall and surveys, respectively. In the qualitative study we conducted staff/governor interviews and pupil focus groups in a subsample of schools. We used multilevel analyses to explore variation in pupil outcomes across the school food standards-mandated and school food standards-non-mandated school groups. Data were analysed using the Framework approach. Results: Thirty-six schools (13 school food standards-mandated, 23 school food standards-non-mandated), 2453 pupils and 151 staff/governors participated. On average, schools were compliant with 64% of school food standards and implemented 41% of School Food Plan actions, with no differences across school food standards-mandated/non-mandated schools. There was a wide variation in annual costs of the school food standards and School Food Plan reported by schools (mean of £195 per pupil). Pupils in school food standards-mandated schools had lower lunch intakes of free sugar than those in school food standards-non-mandated schools (adjusted mean difference = –2.78 g, 95% confidence interval –4.66 to –0.90 g). After further adjustment for total energy intake, there was no significant difference in free sugar intake, but the school food standards-mandated group had lower fruit and vegetable intake at all time points, and higher consumption of confectionery during the school day and sugar-sweetened beverages over 24 hours. There were no differences in dental outcomes between the two groups. Twenty-one staff/governors and 137 pupils participated in the qualitative study. Staff described balancing school food standards compliance with conflicting priorities related to financial viability. Some pupils felt that school food did not meet their needs for convenience, speed, value for money and taste, and disliked the lunchtime experience. Little time was afforded to healthy-eating education within the curriculum. Limitations: There were large numbers of missing data for some study elements, including assessment of some School Food Plan actions and cost data. Conclusions: In the secondary school context, the current school food standards are difficult to comply with and the School Food Plan has not achieved the desired outcomes. We found no evidence to show that school food standards legislation has positively influenced nutritional intake. Future research: We need to develop healthy secondary-school food provision models that meet pupils’ preferences, and better understand how to situate the food and healthy-eating agenda in secondary schools. Trial registration: This trial is registered as ISRCTN68757496. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Public Health Research programme (NIHR award ref: 17/92/39) and is published in full in Public Health Research; Vol. 12, No. 12. See the NIHR Funding and Awards website for further award information.
- 1 November 2024
- Published by National Institute for Health and Care Research in Public Health Research
- Vol. 12 (12) , 1-167
Open AccessSchool food policy in secondary schools in England and its impact on adolescents’ diets and dental health: the FUEL multiple-methods study
Background: School food standards are a legal requirement for state-funded schools in England and are designed to promote healthy eating in pupils. However, state-funded academies/free schools established between 2010 and 2014 are exempt from this legislation. To complement the school food standards, the government launched the School Food Plan in 2013, which outlines voluntary actions that schools can take to support healthy eating and increase school meal uptake. There has been little evaluation of the school food standards and School Food Plan in secondary schools. Objectives: To compare implementation and costs of the school food standards and School Food Plan, and pupil dietary and dental outcomes in two groups of secondary schools: those mandated and those not mandated to comply with the school food standards legislation. Methods: An observational, multiple-methods study. We sampled state-funded secondary school academies/free schools, pupils aged 11–15 years, and school staff/governors with a role in food provision/education from the Midlands. We collected qualitative data in four schools. The primary outcome was pupil free sugar intake at lunch; across the school day; and during 24-hours. Secondary outcomes were additional nutritional outcomes and dental caries measures. We assessed school food standards/School Food Plan implementation and costs using researcher observation, document analysis, and surveys with staff/governors, schools and pupils. Dietary intake and dental outcomes were measured online using 24-hour dietary recall and surveys, respectively. In the qualitative study we conducted staff/governor interviews and pupil focus groups in a subsample of schools. We used multilevel analyses to explore variation in pupil outcomes across the school food standards-mandated and school food standards-non-mandated school groups. Data were analysed using the Framework approach. Results: Thirty-six schools (13 school food standards-mandated, 23 school food standards-non-mandated), 2453 pupils and 151 staff/governors participated. On average, schools were compliant with 64% of school food standards and implemented 41% of School Food Plan actions, with no differences across school food standards-mandated/non-mandated schools. There was a wide variation in annual costs of the school food standards and School Food Plan reported by schools (mean of £195 per pupil). Pupils in school food standards-mandated schools had lower lunch intakes of free sugar than those in school food standards-non-mandated schools (adjusted mean difference = –2.78 g, 95% confidence interval –4.66 to –0.90 g). After further adjustment for total energy intake, there was no significant difference in free sugar intake, but the school food standards-mandated group had lower fruit and vegetable intake at all time points, and higher consumption of confectionery during the school day and sugar-sweetened beverages over 24 hours. There were no differences in dental outcomes between the two groups. Twenty-one staff/governors and 137 pupils participated in the qualitative study. Staff described balancing school food standards compliance with conflicting priorities related to financial viability. Some pupils felt that school food did not meet their needs for convenience, speed, value for money and taste, and disliked the lunchtime experience. Little time was afforded to healthy-eating education within the curriculum. Limitations: There were large numbers of missing data for some study elements, including assessment of some School Food Plan actions and cost data. Conclusions: In the secondary school context, the current school food standards are difficult to comply with and the School Food Plan has not achieved the desired outcomes. We found no evidence to show that school food standards legislation has positively influenced nutritional intake. Future research: We need to develop healthy secondary-school food provision models that meet pupils’ preferences, and better understand how to situate the food and healthy-eating agenda in secondary schools. Trial registration: This trial is registered as ISRCTN68757496. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Public Health Research programme (NIHR award ref: 17/92/39) and is published in full in Public Health Research; Vol. 12, No. 12. See the NIHR Funding and Awards website for further award information.
- Open Access
- 1 September 2024
- Published by National Institute for Health and Care Research in Global Health Research
- p. 1-26
Development and application of a rapid research prioritisation process for identifying health research priorities in low- and middle-income countries: the RAPID-RP stakeholder analysis
Background: Health research should be locally prioritised by key stakeholders to ensure the best use of available resources, maximum likelihood of research leading to uptake into policy and practice and relevance to the needs of the potential beneficiaries. Established approaches are complex and time-consuming, therefore not feasible in settings where prioritisation is uncommon and time is limited. Objectives: We developed and applied a simple, rapid research prioritisation approach to elicit the views of stakeholders. Setting and participants: This was a collaboration between a multidisciplinary group of United Kingdom academics, the International Primary Care Respiratory Group and primary care respiratory researchers from four low- and middle-income countries: Brazil, China, Georgia and North Macedonia. We identified 10 topics for research prioritisation through workshops involving 26 topic, methods and local context experts, and considering the programme remit, to develop, adapt and evaluate culturally appropriate community and behavioural approaches for the prevention, early identification and management of chronic obstructive pulmonary disease in primary care. Design and methods: In each setting, local research teams convened stakeholder groups of patients, clinicians, managers/policymakers and researchers. Each group briefly discussed the 10 potential research study topics. Discussions were facilitated using short vignettes for each topic, and participants were encouraged to consider importance, feasibility and equity. Individual participants rated each study on a three-point traffic light scale, then ranked them following a facilitated discussion on what drove the ratings. The research team rated then ranked each study considering three further criteria (international novelty, potential for future funding and capacity building on a five-point scale). Within each group, ranks were summed to create a final rank order which guided our research programme and provided insight for future projects. Results: In each country, four to eight members attended each stakeholder group. The engagement process was completed in less than 4 hours and feedback was very positive, especially from patients who valued the opportunity to contribute to research decision-making about their own condition. Ranking varied to some extent between groups and settings, but there was consistency around topics that were prioritised among the top five in all groups (identifying efficient chronic obstructive pulmonary disease screening test strategies, evaluations of lung age to aid smoking cessation, feasibility of locally adapted pulmonary rehabilitation, clinical education for primary care staff) and study topics that consistently ranked low (use of e-cigarettes for smoking cessation, weight management to improve chronic obstructive pulmonary disease symptoms and handwashing to reduce infections). Limitations: Despite attempts to maximise inclusivity and diversity, stakeholders were mainly limited geographically to the centres where researchers were based, potentially limiting generalisability of views across the countries. Facilitator styles varied and may have influenced some of the discussions and potentially the ranking. Conclusions: Despite some limitations, we demonstrated the feasibility and acceptability of the rapid research prioritisation approach stakeholder analysis for identifying locally relevant research priorities in low- and middle-income country settings. Future work: Further validation is needed for aspects of the process. We have identified some useful lessons from our evaluation of the process, to facilitate future use of this approach. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Global Health Research programme as award number 16/137/95.
- 1 September 2024
- Published by National Institute for Health and Care Research in Global Health Research
- p. 1-26
Open AccessDevelopment and application of a rapid research prioritisation process for identifying health research priorities in low- and middle-income countries: the RAPID-RP stakeholder analysis
Background: Health research should be locally prioritised by key stakeholders to ensure the best use of available resources, maximum likelihood of research leading to uptake into policy and practice and relevance to the needs of the potential beneficiaries. Established approaches are complex and time-consuming, therefore not feasible in settings where prioritisation is uncommon and time is limited. Objectives: We developed and applied a simple, rapid research prioritisation approach to elicit the views of stakeholders. Setting and participants: This was a collaboration between a multidisciplinary group of United Kingdom academics, the International Primary Care Respiratory Group and primary care respiratory researchers from four low- and middle-income countries: Brazil, China, Georgia and North Macedonia. We identified 10 topics for research prioritisation through workshops involving 26 topic, methods and local context experts, and considering the programme remit, to develop, adapt and evaluate culturally appropriate community and behavioural approaches for the prevention, early identification and management of chronic obstructive pulmonary disease in primary care. Design and methods: In each setting, local research teams convened stakeholder groups of patients, clinicians, managers/policymakers and researchers. Each group briefly discussed the 10 potential research study topics. Discussions were facilitated using short vignettes for each topic, and participants were encouraged to consider importance, feasibility and equity. Individual participants rated each study on a three-point traffic light scale, then ranked them following a facilitated discussion on what drove the ratings. The research team rated then ranked each study considering three further criteria (international novelty, potential for future funding and capacity building on a five-point scale). Within each group, ranks were summed to create a final rank order which guided our research programme and provided insight for future projects. Results: In each country, four to eight members attended each stakeholder group. The engagement process was completed in less than 4 hours and feedback was very positive, especially from patients who valued the opportunity to contribute to research decision-making about their own condition. Ranking varied to some extent between groups and settings, but there was consistency around topics that were prioritised among the top five in all groups (identifying efficient chronic obstructive pulmonary disease screening test strategies, evaluations of lung age to aid smoking cessation, feasibility of locally adapted pulmonary rehabilitation, clinical education for primary care staff) and study topics that consistently ranked low (use of e-cigarettes for smoking cessation, weight management to improve chronic obstructive pulmonary disease symptoms and handwashing to reduce infections). Limitations: Despite attempts to maximise inclusivity and diversity, stakeholders were mainly limited geographically to the centres where researchers were based, potentially limiting generalisability of views across the countries. Facilitator styles varied and may have influenced some of the discussions and potentially the ranking. Conclusions: Despite some limitations, we demonstrated the feasibility and acceptability of the rapid research prioritisation approach stakeholder analysis for identifying locally relevant research priorities in low- and middle-income country settings. Future work: Further validation is needed for aspects of the process. We have identified some useful lessons from our evaluation of the process, to facilitate future use of this approach. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Global Health Research programme as award number 16/137/95.
- 1 August 2024
- Published by Springer Nature
- p. 96-105
Interpretable Machine Learning in Endocrinology: A Diagnostic Tool in Primary Aldosteronism
- 1 August 2024
- Published by Springer Nature
- p. 96-105
Interpretable Machine Learning in Endocrinology: A Diagnostic Tool in Primary Aldosteronism